Lepu Biopharma (2157) Announces Proxy Arrangements for 2025 Second EGM

Bulletin Express11-28

Lepu Biopharma Co., Ltd. (Stock Code: 2157) has released a proxy form in preparation for its 2025 second extraordinary general meeting (EGM), scheduled on December 18, 2025, at 10:30 a.m., at Conference Room, Building 7, No. 37 Chaoqian Road, Changping District, Beijing, the PRC.

According to the announcement, the EGM will consider adopting a Restricted Share Unit Scheme (RSU Scheme) and, subject to relevant approvals, implementing a Scheme Mandate Limit. Another resolution will authorize necessary amendments to the Articles of Association to reflect the issuance of new shares under the RSU Scheme. The announcement also specifies instructions for shareholders to appoint proxies, submit relevant documentation before the deadline, and present valid identification for attendance at the EGM.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment